stoxline Quote Chart Rank Option Currency Glossary
  
XOMA Corporation (XOMA)
26.03  -0.31 (-1.18%)    02-06 11:02
Open: 26.33
High: 26.33
Volume: 2,270
  
Pre. Close: 26.34
Low: 26.03
Market Cap: 307(M)
Technical analysis
2025-02-06 10:52:18 AM
Short term     
Mid term     
Targets 6-month :  31.6 1-year :  33.89
Resists First :  27.05 Second :  29.02
Pivot price 26.4
Supports First :  23.87 Second :  19.86
MAs MA(5) :  25.96 MA(20) :  26.36
MA(100) :  28.32 MA(250) :  26.58
MACD MACD :  -0.4 Signal :  -0.4
%K %D K(14,3) :  31.5 D(3) :  29.2
RSI RSI(14): 47.9
52-week High :  35 Low :  19.5
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ XOMA ] has closed above bottom band by 45.4%. Bollinger Bands are 44.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 0 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 26.37 - 26.48 26.48 - 26.58
Low: 25.27 - 25.38 25.38 - 25.5
Close: 26.15 - 26.34 26.34 - 26.51
Company Description

XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners. It has a portfolio with approximately 70 assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.

Headline News

Wed, 05 Feb 2025
XOMA stock price target cut to $104 by H.C. Wainwright - MSN

Tue, 04 Feb 2025
XOMA Royalty to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference - GlobeNewswire

Tue, 04 Feb 2025
XOMA Royalty to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference - Eagle-Tribune

Tue, 04 Feb 2025
Exclusive Healthcare Insights: XOMA Leadership Takes Center Stage at Oppenheimer Conference - StockTitan

Mon, 03 Feb 2025
Forecasting The Future: 5 Analyst Projections For XOMA Royalty - Benzinga

Sat, 01 Feb 2025
XOMA Co. (NASDAQ:XOMA) Major Shareholder Sells $13,069,366.20 in Stock - MarketBeat

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Underperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Underperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Underperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Biotechnology
Shares Out 12 (M)
Shares Float 8 (M)
Held by Insiders 0.8 (%)
Held by Institutions 59.7 (%)
Shares Short 174 (K)
Shares Short P.Month 139 (K)
Stock Financials
EPS -3.07
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 7.21
Profit Margin -138.7 %
Operating Margin -22.8 %
Return on Assets (ttm) -5.6 %
Return on Equity (ttm) -31.5 %
Qtrly Rev. Growth 767 %
Gross Profit (p.s.) 1.66
Sales Per Share 1.83
EBITDA (p.s.) -1.29
Qtrly Earnings Growth 0 %
Operating Cash Flow -15 (M)
Levered Free Cash Flow -19 (M)
Stock Valuations
PE Ratio -8.57
PEG Ratio 0
Price to Book value 3.64
Price to Sales 14.33
Price to Cash Flow -20.98
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android